Holen Sie sich die Stockscreener-App
15.55
0.78%
-0.20
Schlusskurs vom Vortag:
$15.75
Offen:
$15.73
24-Stunden-Volumen:
44,211
Relative Volume:
0.10
Marktkapitalisierung:
$643.55M
Einnahmen:
$320.17M
Nettoeinkommen (Verlust:
$-36.74M
KGV:
-17.56
EPS:
-0.8856
Netto-Cashflow:
$-2.86M
1W Leistung:
-0.28%
1M Leistung:
+14.99%
6M Leistung:
+36.72%
1J Leistung:
+65.36%
1-Tages-Spanne:
$15.54
$15.75
1-Wochen-Bereich:
$15.47
$16.29
52-Wochen-Spanne:
$9.39
$16.29
Angiodynamic Inc Stock (ANGO) Company Profile
Firmenname
Angiodynamic Inc
Sektor
Telefon
(518) 798-1215
Adresse
14 PLAZA DRIVE, LATHAM
Compare ANGO vs ISRG, BDX, ALC, RMD, MDLN
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
ANGO
Angiodynamic Inc
|
15.57 | 653.88M | 320.17M | -36.74M | -2.86M | -0.8856 |
ISRG
Intuitive Surgical Inc
|
376.08 | 132.30B | 11.03B | 3.16B | 3.22B | 8.7251 |
BDX
Becton Dickinson Co
|
190.74 | 51.11B | 21.37B | 1.41B | 3.07B | 3.9437 |
ALC
Alcon Inc
|
73.57 | 35.25B | 10.63B | 819.00M | 1.59B | 1.6577 |
RMD
Resmed Inc
|
232.21 | 32.95B | 5.54B | 1.52B | 1.74B | 10.37 |
MDLN
Medline Inc
|
34.30 | 28.58B | 29.14B | 1.07B | 1.05B | 1.1956 |
Angiodynamic Inc Stock (ANGO) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-07-16 | Eingeleitet | Lake Street | Buy |
| 2024-04-05 | Hochstufung | Oppenheimer | Perform → Outperform |
| 2023-09-25 | Eingeleitet | H.C. Wainwright | Buy |
| 2023-04-17 | Herabstufung | Raymond James | Strong Buy → Outperform |
| 2021-10-15 | Hochstufung | Canaccord Genuity | Hold → Buy |
| 2021-08-20 | Eingeleitet | Oppenheimer | Perform |
| 2020-11-25 | Hochstufung | Raymond James | Mkt Perform → Strong Buy |
| 2020-04-08 | Herabstufung | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2019-04-01 | Hochstufung | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2018-04-03 | Hochstufung | Raymond James | Mkt Perform → Outperform |
| 2018-01-05 | Herabstufung | Craig Hallum | Buy → Hold |
| 2017-04-07 | Bestätigt | Cantor Fitzgerald | Overweight |
| 2017-03-30 | Herabstufung | KeyBanc Capital Mkts | Overweight → Sector Weight |
| 2017-02-08 | Eingeleitet | Barclays | Equal Weight |
| 2016-11-04 | Eingeleitet | Cantor Fitzgerald | Buy |
| 2016-04-08 | Fortgesetzt | Piper Jaffray | Neutral |
| 2016-01-08 | Bestätigt | Canaccord Genuity | Buy |
| 2015-11-10 | Herabstufung | Raymond James | Outperform → Mkt Perform |
| 2015-07-24 | Eingeleitet | KeyBanc Capital Mkts | Overweight |
| 2014-06-19 | Hochstufung | Canaccord Genuity | Hold → Buy |
| 2012-10-09 | Bestätigt | Canaccord Genuity | Hold |
| 2012-06-25 | Herabstufung | Canaccord Genuity | Buy → Hold |
| 2011-07-15 | Hochstufung | Canaccord Genuity | Hold → Buy |
| 2011-07-15 | Hochstufung | Stifel Nicolaus | Hold → Buy |
| 2011-06-14 | Herabstufung | Wedbush | Neutral → Underperform |
| 2010-09-08 | Bestätigt | Wedbush | Neutral |
Alle ansehen
Angiodynamic Inc Aktie (ANGO) Neueste Nachrichten
387,188 Shares in AngioDynamics, Inc. $ANGO Bought by Western Standard LLC - MarketBeat
AngioDynamics, Inc. (ANGO) Presents at Canaccord Genuity's 46th Annual Growth ConferenceSlideshow - Seeking Alpha
AngioDynamics, Inc. (ANGO) Stock Analysis: Uncovering a 32% Potential Upside with Robust Buy Ratings - DirectorsTalk Interviews
AngioDynamics, Inc. $ANGO Shares Purchased by Lazard Asset Management LLC - MarketBeat
Segall Bryant & Hamill LLC Trims Stock Position in AngioDynamics, Inc. $ANGO - MarketBeat
AngioDynamics, Inc. (NASDAQ:ANGO) Receives Consensus Rating of "Hold" from Analysts - MarketBeat
AngioDynamics (ANGO) SVP Warren Nighan Jr. sells 23,370 shares at $14.72 - Stock Titan
AngioDynamics (NASDAQ: ANGO) insider plans $344K sale of equity awards - Stock Titan
AngioDynamics Number of Employees 2026 | Employee Count & Headcount Data - Revelio Labs
Live webcast set for AngioDynamics' Aug. 11 presentation - Stock Titan
AngioDynamics Inc (ANGO) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
AngioDynamics, Inc. Revenue Breakdown – NASDAQ:ANGO - TradingView
AngioDynamics Inc. (ANGO) SVP receives 8,047 shares, 4,506 withheld for tax - Stock Titan
AngioDynamics (NASDAQ: ANGO) executive settles 20,052 performance units - Stock Titan
AngioDynamics (NASDAQ: ANGO) CEO settles performance share grant - Stock Titan
AngioDynamics Inc (ANGO) CFO performance shares vest, tax withheld - Stock Titan
AngioDynamics (ANGO) SVP receives shares from PSU vesting, with tax withholding - Stock Titan
Form 4 AngioDynamics Inc For: 22 July By Investing.com - Investing.com Canada
AngioDynamics (ANGO) director receives 11,887-share stock award - Stock Titan
AngioDynamics Inc. (ANGO) awards 17,966 RSUs and performance rights - Stock Titan
ETFs Investing in AngioDynamics, Inc. Stocks - TradingView
AngioDynamics Inc (ANGO) director awarded 11,887 shares in annual grant - stocktitan.net
AngioDynamics (ANGO) SVP uses 8,228 shares to cover RSU tax obligations - Stock Titan
AngioDynamics (ANGO) CFO withholds 12,067 shares to satisfy RSU tax obligations - Stock Titan
AngioDynamics (ANGO) SVP covers tax obligations through share withholding - Stock Titan
AngioDynamics: NanoKnife Momentum Looks Real, But Much Of The Good News Is Priced In - Seeking Alpha
AngioDynamics, Inc. $ANGO Shares Bought by Bastion Asset Management Inc. - marketbeat.com
AngioDynamics: Growth Is Working, Price Knows It (Rating Downgrade) - Seeking Alpha
AngioDynamics Q4 Earnings Beat Estimates, Gross Margin Expands - TradingView
AngioDynamics (NASDAQ: ANGO) details device portfolio and risk factors - Stock Titan
ANGIODYNAMICS INC FY 2026: Revenue $320.17M, EPS ($0.88) — 10-K Summary - TradingView
Is AngioDynamics Inc (ANGO) Overvalued After Q4 Earnings Miss? E - GuruFocus
AngioDynamics Inc reports results for the quarter ended May 31Earnings Summary - TradingView
AngioDynamics, Inc. 2026 Q4ResultsEarnings Call Presentation (NASDAQ:ANGO) 2026-07-14 - Seeking Alpha
AngioDynamics Releases Q4 2026 Financial Results - AlphaStreet
Record 2026 sales as AngioDynamics (NASDAQ: ANGO) grows Med Tech 18% - Stock Titan
AngioDynamics: Fiscal Q4 Earnings Snapshot - KVUE
AngioDynamics Inc expected to post a loss of 9 cents a shareEarnings Preview - TradingView
Enterprise value to revenue forward of AngioDynamics, Inc. – NASDAQ:ANGO - TradingView
Price to earnings forward of AngioDynamics, Inc. – NASDAQ:ANGO - TradingView
Enterprise value to EBIT forward of AngioDynamics, Inc. – NASDAQ:ANGO - TradingView
ANGOAngiodynamic Inc Latest SEC Filings - Finviz
Price to sales forward of AngioDynamics, Inc. – NASDAQ:ANGO - TradingView
Price to sales forward of AngioDynamics, Inc. – LS:A0B9A5 - TradingView
Press Release: AngioDynamics to Report Fiscal 2026 Fourth Quarter and Full-Year Financial Results on July 14, 2026 - Moomoo
AngioDynamics sets July 14 call for fiscal 2026 results - Stock Titan
AngioDynamics, Inc.(NasdaqGS: ANGO) added to Russell 2000 Value-Defensive Index - marketscreener.com
AngioDynamics, Inc. Actuals & Estimates (NASDAQ:ANGO) - TradingView
ANGO Forecast — Price Target — Prediction for 2027 - TradingView
AngioDynamics Inc. (ANGO) Rises 5.25%: Support and Resistance Levels in FocusInitial Balance - dars.gov.et
Reasons to Hold AngioDynamics Stock in Your Portfolio for Now - TradingView
Finanzdaten der Angiodynamic Inc-Aktie (ANGO)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.82%
0.93%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):